Terry Watnick, MD
Nephrology · Baltimore, MDNPI 1275579989
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,050 of the $3,211 with a category attached, or 95.0%. Sanofi accounts for 95.0% of it on its own, with 2 other manufacturers making up the rest.
Across 3 payments — averaging $1070.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- Mallinckrodt Enterprises LLC$100
- Otsuka America Pharmaceutical, Inc.$61
Across 3 payments — averaging $33,591 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$63K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$38K
What the payments were for
- Consulting fees$3,05095%
- Education$1615%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 1 | $3,050 |
| Mallinckrodt Enterprises LLC | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. | 1 | $61 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FABRAZYME$3,050
How this compares
$3,211 in reported general payments places this provider in the 75th percentile of 285 nephrology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Baltimore
- Matthew WeirBaltimore$490K
- Chirag ParikhBaltimore$186K
- Mohamad HanounehBaltimore$174K
- Daniel BrennanBaltimore$133K
- Monika DhillonBaltimore$126K
- Duvuru GeethaBaltimore$91K
- Mohamed AttaBaltimore$65K
- Michelle EstrellaBaltimore$55K
- Zainab ObaidiBaltimore$39K
- Christopher SperatiBaltimore$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.